The company’s rabies candidate, RBI-4000, was able to elicit an immune response comparable to Bavarian Nordic’s RavAvert.

A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and ...

(NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the appointment of Arthur Levin, PhD, to the Company’s Strategic ...

WVE-007 is a novel, long-acting GalNAc-siRNA targeting INHBE mRNA – a genetically validated target that provides a new approach for healthy, ...

While some of the initial zeal around localized vaccine production in Africa has waned since the height of the COVID-19 pandemic, efforts to bolster the continent’s immunization autonomy—especially | ...

Rock and dust samples brought back to Earth from the asteroid Bennu contain organic matter and a variety of minerals crucial to the emergence of life ...

Idaho state Sen. Brandon Shippy, R-New Plymouth proposed a bill that would ban COVID vaccines, and others created with memory ...

The field of plant biotechnology is undergoing a profound transformation. The rise of generative artificial intelligence (AI) ...

Newco Akribion Therapeutics GmbH has raised €8 million (US$8.3 million) in a seed round to develop a new and potent class of RNA-targeted CRISPR nucleases, which, rather than cleaving specific nucleic ...

Asteroid Bennu seems to have come from a long-lost world on the fringes of the solar system, where saltwater pooled and dried ...

The Mirvie RNA Platform found severe growth restriction has a unique RNA signature independent of preeclampsia, chronic hypertension, and gestational diabetes, all of which can impact fetal growth.